VC and Investment
Biotechnology
As India's bioeconomy soars to a remarkable valuation of $151 billion, the government's Biotechnology Industry Research Assistance Council (BIRAC) has underscored the critical need for innovation and private sector investment to unlock further growth. 21 October 2024
Today's issue
Refine Search
Pharmaceutical
Privately held Presage Biosciences on Thursday said it has secured an investment from Japan’s largest drugmaker Takeda Pharmaceutical without disclosing any terms. 20 August 2015
Generics
Shares in Jordon-based drugmaker Hikma Pharma dropped nearly 2% in early trading Thursday on the London Stock Exchange as the company posted a 21% fall in first half 2015 earnings. 20 August 2015
Pharmaceutical
Alk-Abello A/S has swung to a second-quarter 2015 loss hurt by a 44% drop in revenue from North America on the back of special items. 18 August 2015
Generics
Shares in India-based pharma company Cipla dropped over 4.5% on the Bombay Stock Exchange even as the company more than doubled first-quarter profit. 17 August 2015
Biotechnology
Genmab reported a surge in first half 2015 operating income year-on-year driven by a one-time gain and lower expenses as revenue dropped 23%. 12 August 2015
Pharmaceutical
India-based pharma company Zydus Cadila on Wednesday reported a 47% jump in first-quarter profit and announced a five-for-one stock split for its shares. 12 August 2015
Pharmaceutical
Orexigen Therapeutics on Thursday said it has partnered with Kwang Dong Pharmaceutical to distribute weight loss medication in South Korea for an upfront payment of $7 million. 6 August 2015
Pharmaceutical
German pharmaceutical firm Merck KGaA on Thursday posted a 13.2% rise in net profit for the second quarter boosted by favourable currency impact. 6 August 2015
Generics
Mallinckrodt on Tuesday posted third quarter (ended June 30) results ahead of estimates boosted by sales from the company’s recently acquired H.P. Acthar Gel (repository corticotropin injection) and Inomax (nitric oxide). 4 August 2015
Pharmaceutical
Belgian pharmaceutical company UCB raised its outlook for 2015 as first-half sales beat estimates boosted by revenue from three major drugs. 3 August 2015
Pharmaceutical
French drugmaker Ipsen on Friday posted a 7.9% rise in first-half 2015 sales, driven by a strong 12% growth of specialty care, especially due to its top-selling Somatuline (lanreotide), to treat gastrointestinal and pancreatic tumors. 31 July 2015
Generics
India-based Dr Reddy’s Laboratories posted a rise in first quarter revenue and profit boosted by growth in generics sales in the USA, Europe and India despite few new launches and currency devaluation in key emerging markets. 31 July 2015
Pharmaceutical
Anglo-Swedish drug major AstraZeneca on Thursday posted a 2% rise in second-quarter revenue ahead of estimates as the company continues heavy investment in research and development of new product pipeline. 30 July 2015
Pharmaceutical
Italy-based Recordati on Wednesday raised its sales estimates for the full year 2015 and reported a 24.3% rise in first-half net profit. 29 July 2015
Generics
Generics specialist Mylan has moved to block a hostile takeover bid by Israeli company Teva by setting up an independent Dutch foundation which has exercised its call option to acquire preferred shares in Mylan. 24 July 2015
Pharmaceutical
Swedish pharma company Karolinska Development is divesting its entire shareholding in Pharmanest to a consortium consisting of The Foundation for Baltic and East European Studies (Östersjöstiftelsen), Recipharm Venture Fund and Praktikerinvest. 9 July 2015
Biotechnology
Celladon has issued a business update detailing its intention to suspend further development of its experimental gene therapy Mydicar and other clinical programs. 28 June 2015
Pharmaceutical
Swiss drug major Novartis has highlighted its strong innovation momentum and said it expects to increase core margin in 2015 due to portfolio transformation. 18 June 2015
Pharmaceutical
Germany’s Merck KGaA has received clearance from the European Commission to acquire US-based life science company Sigma-Aldrich. 16 June 2015
Biotechnology
Iclaprim, a new antibiotic from Motif Bio, could fill a major market void and achieve over $1 billion in sales per year, according to analysts at Northland Capital Partners. 27 May 2015
Biotechnology
San Francisco, USA-based biotech start-up Kivu Bioscience has announced the closing of a $92 million Series A financing round led by Novo Holdings, which as of year-end 2011123 had total assets of 149 billion euros ($161 billion). 28 October 2024
Biotechnology
Ottimo Pharma, a biotech founded by Medicxi in 2020, has emerged from stealth mode with an executive team packed with prominent industry leaders. 28 October 2024
Biotechnology
Biostar Pharmaceuticals has announced its upcoming initial public offering (IPO) on the Hong Kong Stock Exchange, aiming to raise funds to advance its growing oncology pipeline and support its global expansion efforts. 25 October 2024
Biotechnology
Belgian biotech Agomab Therapeutics today announced a $89 million (82.1 million euros) Series D financing round, with participation from new investors Sanofi and Invus 25 October 2024
Pharmaceutical
Alpha-9 Oncology, a Canadian radiopharmaceutical company, has raised $175 million in an oversubscribed series C financing round led by Lightspeed Venture Partners and Ascenta Capital. 24 October 2024
Biotechnology
US clinical-stage biotech AvenCell Therapeutics announced that it has raised $112 million in Series B financing, which was led by global life sciences investor Novo Holdings. 23 October 2024
Biotechnology
Boston, USA-based Seaport Therapeutics has announced the closing of an oversubscribed $225 million Series B financing round, adding to the $100 million it pulled in along with its launch in April. 21 October 2024
Biotechnology
As India's bioeconomy soars to a remarkable valuation of $151 billion, the government's Biotechnology Industry Research Assistance Council (BIRAC) has underscored the critical need for innovation and private sector investment to unlock further growth. 21 October 2024
Biotechnology
LaNova Medicines, a Shanghai-based biopharma company, has announced that it has secured 3 billion yuan ($41 million) in its series C funding round. 18 October 2024
Biotechnology
California, USA-based biotech Terray Therapeutics, yesterday announced the closing of an oversubscribed Series B funding of $120 million. 18 October 2024
Pharmaceutical
Sanofi has entered into an agreement with Orano Med, a subsidiary of the Orano Group, to advance the development of radioligand therapies for rare cancers. 17 October 2024
Pharmaceutical
Netherlands-based life sciences venture capital firm Forbion has raised more than 2 billion euros ($2.2 billion) across its two newest funds. 16 October 2024
Pharmaceutical
The American Lung Association Research Institute has announced a $22 million research investment in 2024, marking one of the largest lung health research programs in the USA. 16 October 2024
Pharmaceutical
TenNor Therapeutics, a Suzhou-based clinical-stage biotech company, has announced the initial closing of a series E financing round, raising over 300 million yuan ($41 million). 16 October 2024
Biotechnology
In Cambridge, UK, the protein specialist Nuclera has raised $75 million in a funding round led by Elevage Medical Technologies and backed by Patient Square Capital. 16 October 2024
Biotechnology
Tolerance Bio has announced the closing of its oversubscribed $17.2 million seed financing round, led by Columbus Venture Partners. 16 October 2024
Biotechnology
In Hong Kong, Akeso Biopharma has successfully raised $250 million through a share placement, marking its second major fundraising effort of 2024. 15 October 2024
Pharmaceutical
French biopharma company Inventiva has announced financing of immediately 94.1 million euros ($103 million) and up to 348 million euros, subject to satisfaction of specified conditions. 15 October 2024
Biotechnology
Turnstone Biologics has announced a major restructuring of its operations, cutting its workforce by approximately 60%. 14 October 2024
Biotechnology
Boston, USA-based Upstream Bio, a biotech developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders, has made an impressive start to life as a public-listed company.00000 14 October 2024
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze